Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 3
2011 1
2012 2
2013 1
2014 1
2015 3
2016 5
2017 5
2018 8
2019 9
2020 9
2021 8
2022 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.
Hirano T, Hayashi T, Sugita H, Tamasawa A, Goto S, Tomoyasu M, Yamamoto T, Ohara M, Terasaki M, Kushima H, Ito Y, Yamagishi SI, Mori Y. Hirano T, et al. Among authors: mori y. J Diabetes Investig. 2023 Dec;14(12):1401-1411. doi: 10.1111/jdi.14076. Epub 2023 Aug 30. J Diabetes Investig. 2023. PMID: 37647503 Free PMC article. Clinical Trial.
Anti-inflammatory and atheroprotective properties of glucagon.
Osaka N, Kushima H, Mori Y, Saito T, Hiromura M, Terasaki M, Yashima H, Ohara M, Fukui T, Matsui T, Hirano T, Yamagishi SI. Osaka N, et al. Among authors: mori y. Diab Vasc Dis Res. 2020 May-Jun;17(5):1479164120965183. doi: 10.1177/1479164120965183. Diab Vasc Dis Res. 2020. PMID: 33076703 Free PMC article.
Legumain Promotes Atherosclerotic Vascular Remodeling.
Ozawa N, Sato Y, Mori Y, Masuda H, Yamane M, Yamamoto Y, Shirai R, Watanabe R, Sato K, Mori Y, Hirano T, Watanabe T. Ozawa N, et al. Among authors: mori y. Int J Mol Sci. 2019 May 4;20(9):2195. doi: 10.3390/ijms20092195. Int J Mol Sci. 2019. PMID: 31060209 Free PMC article.
Inhibitory effects of vasostatin-1 against atherogenesis.
Sato Y, Watanabe R, Uchiyama N, Ozawa N, Takahashi Y, Shirai R, Sato K, Mori Y, Matsuyama T, Ishibashi-Ueda H, Hirano T, Watanabe T. Sato Y, et al. Among authors: mori y. Clin Sci (Lond). 2018 Dec 5;132(23):2493-2507. doi: 10.1042/CS20180451. Print 2018 Dec 12. Clin Sci (Lond). 2018. PMID: 30401690
Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study.
Omachi T, Ohara M, Fujikawa T, Kohata Y, Sugita H, Irie S, Terasaki M, Mori Y, Fukui T, Yamagishi SI. Omachi T, et al. Among authors: mori y. Diabetes Ther. 2024 Jan;15(1):111-126. doi: 10.1007/s13300-023-01493-3. Epub 2023 Oct 25. Diabetes Ther. 2024. PMID: 37880502 Free PMC article.
62 results